The association between NT-proBNP concentrations and mortality risk did not substantially change in the sensitivity analyses using the WHO-defined BMI categories, except for the obesity group (BMI ≥ 30 kg/m2) (Additional file 8). This evidence concerns the gene NPPB and obesity disorder.